Product Information
GLYBURIDE MICRO 1.5 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1600 per EA under NDC 00093803401. Its NADAC has been published 221 times since Nov 28, 2013.
FDA first approved this application on Apr 20, 1999.
Strength
1.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093803401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
1/22/2025
Active Ingredients
GLYBURIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074686FDA Approved
4/20/1999
On Market Since
5/11/1999
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE MICRO 1.5 MG TAB has been published 221 times since Nov 28, 2013, and over the history we have for it it has risen 253.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1600 per EA |
|---|---|
| All-time high | $0.1610 (Nov 13, 2024) |
| All-time low | $0.0338 (Jul 22, 2015) |
| 52-week high | $0.1600 |
| 52-week low | $0.1600 |
| Median price | $0.0508 |
| Average price | $0.0809 |
| Largest weekly change | +216.9% (Sep 18, 2024) |
| Weeks tracked | 221 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+214.9%
5Y
+214.9%
All
+253.3%
Last surveyed Jan 14, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Glyburide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glyburide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonylurea class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYBURIDE MICRO 1.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE MICRO 1.5 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.1600 per EA (NDC 00093803401), effective Jan 14, 2026.
How has the price of GLYBURIDE MICRO 1.5 MG TAB changed over time?
Over the history we have for it, the NADAC for GLYBURIDE MICRO 1.5 MG TAB has risen 253.3%. It has been tracked across 221 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLYBURIDE MICRO 1.5 MG TAB?
Since Nov 28, 2013, the NADAC for GLYBURIDE MICRO 1.5 MG TAB has ranged from a low of $0.0338 (Jul 22, 2015) to a high of $0.1610 (Nov 13, 2024), with a median of $0.0508 per EA.
Are there cheaper alternatives to GLYBURIDE MICRO 1.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of GLYBURIDE MICRO 1.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GLYBURIDE MICRO 1.5 MG TAB?
GLYBURIDE MICRO 1.5 MG TAB (NDC 00093803401) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.